Emerging Hub for Pharmacoeconomics and Outcomes Research: Asia-Pacific Region

Yang, Bong-Min

doi:10.1016/j.vhri.2013.03.004

Cited by 2 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacoeconomics have been formally adopted by South Korea, Thailand and Taiwan. 38 The National Evidence Based Health Care Agency has been set up in South Korea. This agency is responsible for reviewing evidence related to health economics.…”

Section: Asian Development In the Pharmacoeconomicsmentioning

confidence: 99%

“…Similarly, Indonesia has also adopted pharmacoeconomic guidelines which are being used by the Ministry of Health for clinical decision making. 38 International Society of Pharmacoeconomics and Outcomes Research Asia Consortium have been established to provide a platform for integration of Pharmacoeconomics in clinical decision making in Asian countries. 35 Thorat et al has reported the current state of cost utility analyses in Asia.…”

Section: Asian Development In the Pharmacoeconomicsmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacoeconomics Status in Asia and an Emerging Hub in the Indo-Pak

Sadia¹,

Rehman²,

Sattar³

2019

IJPER

View full text Add to dashboard Cite

Objective: A review has been carried out to understand pharmacoeconomics and its development in the Asian region. Findings: Pharmacoeconomics is a subset of health economics which applies the methodologies and principles of health economics in clinical decision making. Currently, a number of countries around the globe have implemented pharmacoeconomics in their health care systems. However, the development of pharmacoeconomics in the Asia is very debatable. With countries like South Korea, Japan, China and Thailand where health economics is not only being implemented but is also progressing very rapidly, the southern part of Asia specifically India and Pakistan are far behind. Summary: Pharmacoecomics is in very infancy in the South Asia especially in India and Pakistan. It is the need of the hour to improve the practice and development of new pharmacoeconomics guidelines to meet up the standards of the remaining world.

show abstract

Section: Asian Development In the Pharmacoeconomicsmentioning

confidence: 99%

Section: Asian Development In the Pharmacoeconomicsmentioning

confidence: 99%